UPDATE 2-Thermo Fisher buys Henogen for nearly $880 mln in gene therapy expansion
Thermo Fisher Scientific Inc said on Friday it completed its 725 million euros ($879.72 million) acquisition of Belgium-based Henogen SA that will help strengthen the medical device maker's position in the fast-growing field of gene therapy manufacturing.